Clark Adrienne L, Fonarow Gregg C, Horwich Tamara B
Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
Am J Cardiol. 2015 Jan 15;115(2):209-13. doi: 10.1016/j.amjcard.2014.10.023. Epub 2014 Oct 30.
Although high body mass index (BMI) is associated with improved outcomes in established heart failure (HF), the impact of cardiorespiratory fitness on this obesity paradox is less clear. We studied 1,675 patients with systolic HF who underwent cardiopulmonary exercise testing at a single university center (77.4% men, mean age 52.2 ± 11.6 years, mean left ventricular ejection fraction 23.2 ± 7.1% and New York Heart Association class III or IV in 79.1%). We evaluated 2-year survival in patients stratified by both BMI (normal 18.5 to 24.9 kg/m(2)[reference], overweight 25 to 29.9 kg/m(2), obese ≥30.0 kg/m(2)) and by peak oxygen uptake (PKVO2; high >14 ml/kg/minute, low ≤14 ml/kg/minute). At 2 years, BMI category was significantly associated with outcomes for the low PKVO2 group (p <0.001) but not the high PKVO2 group (p = 0.1). In the low PKVO2 group, obese patients had decreased risk of death free from urgent status 1A heart transplant or ventricular assist device placement after multivariate adjustment compared with normal BMI (hazard ratio [HR] 0.64, 95% confidence interval [CI] 0.44 to 0.91, p = 0.01); no significant difference was observed for overweight patients (HR 0.91, 95% CI 0.66 to 1.25, p = 0.5). In the high PKVO2 group, no relation was seen (overweight BMI HR 0.75, 95% CI 0.43 to 1.32, p = 0.3; obese HR 0.87, 95% CI 0.43 to 1.75, p = 0.7). In conclusion, the obesity paradox was only observed in patients with lower cardiorespiratory fitness in this advanced systolic HF cohort, indicating that improved functional capacity may attenuate the obesity paradox.
尽管高体重指数(BMI)与已确诊的心力衰竭(HF)患者预后改善相关,但心肺适能对这种肥胖悖论的影响尚不清楚。我们研究了1675例收缩性HF患者,这些患者在一所大学中心接受了心肺运动测试(男性占77.4%,平均年龄52.2±11.6岁,平均左心室射血分数23.2±7.1%,79.1%为纽约心脏协会III或IV级)。我们评估了按BMI(正常18.5至24.9kg/m²[参考值]、超重25至29.9kg/m²、肥胖≥30.0kg/m²)和峰值摄氧量(PKVO2;高>14ml/kg/分钟、低≤14ml/kg/分钟)分层的患者的2年生存率。在2年时,BMI类别与低PKVO2组的预后显著相关(p<0.001),但与高PKVO2组无关(p = 0.1)。在低PKVO2组中,与正常BMI相比,肥胖患者在多变量调整后无紧急状态1A心脏移植或心室辅助装置植入的死亡风险降低(风险比[HR]0.64,95%置信区间[CI]0.44至0.91,p = 0.01);超重患者未观察到显著差异(HR 0.91,95%CI 0.66至1.25,p = 0.5)。在高PKVO2组中,未发现相关性(超重BMI HR 0.75,95%CI 0.43至1.32,p = 0.3;肥胖HR 0.87,95%CI 0.43至1.75,p = 0.7)。总之,在这个晚期收缩性HF队列中,仅在心肺适能较低的患者中观察到肥胖悖论,这表明功能能力的改善可能会减弱肥胖悖论。